Skip to main content
PMC home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
letter
. 2018 Aug 7;61(10):1280–1282. doi: 10.1007/s11427-018-9343-8

A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice

Peihua Niu 1,#, Guangyu Zhao 2,#, Yao Deng 1, Shihui Sun 2, Wenling Wang 1, Yusen Zhou 2,✉, Wenjie Tan 1,✉
PMCID: PMC7089443  PMID: 30091015

The content is available as a PDF (307.9 KB).

Electronic supplementary material

Supporting Information (325.9KB, docx)

Acknowledgements

We thank Dr. Bart L. Haagmans and Dr. Ron A.M. Fouchier (Erasmus MC, Rotterdam, the Netherlands) for providing MERSCoV (isolate hCoV-EMC/2012). This work was supported by the National Key Research and Development Program of China (2016YFD0500300 to Wenjie Tan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Footnotes

Contributed equally to this work

Contributor Information

Yusen Zhou, Email: yszhou@bmi.ac.cn.

Wenjie Tan, Email: tanwj28@163.com.

References

  1. Agrawal A.S., Ying T., Tao X., Garron T., Algaissi A., Wang Y., Wang L., Peng B.H., Jiang S., Dimitrov D.S., et al. Passive transfer of A germline-like neutralizing human monoclonal antibody protects transgenic mice against lethal middle east respiratory syndrome coronavirus infection. Sci Rep. 2016;6:31629. doi: 10.1038/srep31629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Qiu H., Sun S., Xiao H., Feng J., Guo Y., Tai W., Wang Y., Du L., Zhao G., Zhou Y. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection. Antiviral Res. 2016;132:141–148. doi: 10.1016/j.antiviral.2016.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Shi W., Li J., Zhou H., Gao G.F. Pathogen genomic surveillance elucidates the origins, transmission and evolution of emerging viral agents in China. Sci China Life Sci. 2017;60:1317–1330. doi: 10.1007/s11427-017-9211-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Smith K., Garman L., Wrammert J., Zheng N.Y., Capra J.D., Ahmed R., Wilson P.C. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc. 2009;4:372–384. doi: 10.1038/nprot.2009.3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ying T., Du L., Ju T.W., Prabakaran P., Lau C.C.Y., Lu L., Liu Q., Wang L., Feng Y., Wang Y., et al. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol. 2014;88:7796–7805. doi: 10.1128/JVI.00912-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Zaki A.M. v, Boheemen S., Bestebroer T.M., Osterhaus A.D.M.E., Fouchier R.A.M. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–1820. doi: 10.1056/NEJMoa1211721. [DOI] [PubMed] [Google Scholar]
  7. Zhao G., Du L., Ma C., Li Y., Li L., Poon V.K., Wang L., Yu F., Zheng B.J., Jiang S., et al. A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV. Virol J. 2013;10:266. doi: 10.1186/1743-422X-10-266. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information (325.9KB, docx)

Articles from Science China. Life Sciences are provided here courtesy of Nature Publishing Group

RESOURCES